Matthias Bodenstedt
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+20.4%
vs. S&P 500+17.3%
Beat the market100%
Paper profit on buys+$19K
Total bought / sold$99K / $3.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 23SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 39,1201,115,435 held (−3%) | $22.04 | $862K | -50.9% |
| Jun 18SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 15,0821,157,349 held (−1%) | $19.68 | $297K | -45.0% |
| Jun 18SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 2,7941,154,555 held (−0%) | $19.60 | $55K | -44.8% |
| May 13SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 13,6531,172,431 held (−1%) | $20.02 | $273K | -46.0% |
| Apr 16SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 2,4261,186,084 held (−0%) | $19.56 | $47K | -44.7% |
| Apr 10SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 85,8701,190,435 held (−7%) | $18.94 | $1.6M | -42.9% |
| Apr 10SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 1,9251,188,510 held (−0%) | $19.51 | $38K | -44.5% |
| Oct 9SEC | MLTXMoonLake Immunotherapeutics | Buy | 10,870627,536 held (+2%) | $9.09 | $99K | +19.0% |
- Sell
CFO Matthias Bodenstedt sold $862K of MLTX at $22.04 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthias Bodenstedt sold $297K of MLTX at $19.68 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthias Bodenstedt sold $55K of MLTX at $19.60 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthias Bodenstedt sold $273K of MLTX at $20.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthias Bodenstedt sold $47K of MLTX at $19.56 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Matthias Bodenstedt sold $1.6M of MLTX at $18.94 — pre-scheduled 10b5-1 plan sale.